Variables | Survivors | Non-survivors | Full sample | P |
---|---|---|---|---|
Sex | ||||
Male | 84 (60.0) | 14 (66.6) | 98 (60.9) | 0.637 |
Female | 56 (40.0) | 7 (33.4) | 63 (39.1) | |
Age | 43.1 ± 15.7 | 53.6 ± 11.9 | 44.5 ± 15.6 | 0.002 |
Socioeconomic status a | ||||
B | 4 (2.9) | 3 (14.3) | 7 (4.3) | |
C | 33 (23.6) | 5 (23.8) | 38 (23.6) | |
D | 81 (57.9) | 13 (61.9) | 94 (58.4) | |
E | 22 (15.7) | 0 | 22 (13.7) | |
Primary kidney disease | ||||
Glomerulonephritis | 64 (45.7) | 5 (23.8) | 69 (42.9) | 0.063 |
Hypertension | 31 (22.1) | 7 (33.4) | 38 (23.6) | 0.276 |
Diabetes | 12 (8.6) | 4 (19.0) | 16 (9.9) | 0.230 |
Policystic kidney | 9 (6.4) | 2 (9.5) | 11 (6.8) | 0.117 |
Obstructive uropathy | 6 (4.2) | 1 (4.8) | 7 (4.3) | 1.000 |
Lupus | 4 (2.9) | 0 | 4 (2.5) | 1.000 |
Chronic pyelonephritis | 4 (2.9) | 0 | 4 (2.5) | 0.658 |
Indeterminate | 10 (7.2) | 2 (9.5) | 12 (7.5) | 1.000 |
Time on dialysis (months) | 55.4 ± 52.8 | 50.9 ± 39.5 | 54.8 ± 51.2 | 0.989 |
Comorbidity b | ||||
Low | 115 (82.2) | 11 (52.4) | 126 (78.3) | 0.002 |
Medium | 22 (15.7) | 6 (28.6) | 28 (17.4) | |
High | 3 (2.1) | 4 (19.0) | 7 (4.3) | |
Included on transplant waiting list | 80 (57.1) | 5 (23.8) | 85 (52.7) | 0.005 |
Laboratory tests | ||||
Creatinine (mg/dl) | 12.7 ± 3.6 | 11.8 ± 4.0 | 12.6 ± 3.6 | 0.140 |
Hemoglobin (g/dl) | 8.5 ± 1.7 | 8.2 ± 1.6 | 8.5 ± 1.7 | 0.665 |
Albumin (g/dl) | 4.3 ± 0.4 | 4.4 ± 0.5 | 4.3 ± 0.4 | 0.567 |
Calcium-phosphorus product (mg2/dl2) | 46.2 ± 13.0 | 49.6 ± 15.6 | 46.6 ± 13.4 | 0.476 |
Kt/V index | 1.5 ± 0.5 | 1.6 ± 0.5 | 1.5 ± 0.5 | 0.807 |